Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives
Abstract Background In the past years, there has been a notable increase in interest regarding targeted alpha therapy using Ac-225, driven by the observed promising clinical anti-tumor effects. As the production and technology has advanced, the availability of Ac-225 is expected to increase in the n...
Saved in:
Main Authors: | Eline L. Hooijman (Author), Valery Radchenko (Author), Sui Wai Ling (Author), Mark Konijnenberg (Author), Tessa Brabander (Author), Stijn L. W. Koolen (Author), Erik de Blois (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of [<sup>225</sup>Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
by: Eline L. Hooijman, et al.
Published: (2021) -
Advances in <sup>177</sup>Lu-PSMA and <sup>225</sup>Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
by: Sui Wai Ling, et al.
Published: (2022) -
A suitable time point for quantifying the radiochemical purity of 225Ac-labeled radiopharmaceuticals
by: James M. Kelly, et al.
Published: (2021) -
First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
by: Maryana Handula, et al.
Published: (2023) -
Evaluation of Actinium-225 Labeled Minigastrin Analogue [<sup>225</sup>Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
by: Yun Qin, et al.
Published: (2020)